{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T04:09:40Z","timestamp":1772424580859,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010600","name":"Tays","doi-asserted-by":"publisher","award":["R16184"],"award-info":[{"award-number":["R16184"]}],"id":[{"id":"10.13039\/501100010600","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.preghy.2020.06.008","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T20:41:28Z","timestamp":1594068088000},"page":"7-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Therapeutic doses of metformin do not have impact on angiogenesis in presence of sera from pre-eclamptic, IUGR and healthy pregnancies"],"prefix":"10.1016","volume":"22","author":[{"given":"Anita","family":"Virtanen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Outi","family":"Huttala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kati","family":"Tihtonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarja","family":"Toimela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuula","family":"Heinonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannele","family":"Laivuori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jukka","family":"Uotila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.preghy.2020.06.008_b0005","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7326\/M16-1901","article-title":"Clinical outcomes of metformin use in populations with chronic kidney disease, congestive heart failure, or chronic liver disease: a systematic review","volume":"166","author":"Crowley","year":"2017","journal-title":"Ann. Internal Med."},{"issue":"7503","key":"10.1016\/j.preghy.2020.06.008_b0010","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"issue":"9741","key":"10.1016\/j.preghy.2020.06.008_b0015","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","article-title":"Pre-eclampsia","volume":"376","author":"Steegers","year":"2010","journal-title":"Lancet (London, England)."},{"key":"#cr-split#-10.1016\/j.preghy.2020.06.008_b0020.1","doi-asserted-by":"crossref","unstructured":"S.A. Karumanchi, Angiogenic factors in preeclampsia: from diagnosis to therapy. Hypertens. (Dallas, Tex 1979). 67","DOI":"10.1161\/HYPERTENSIONAHA.116.06421"},{"key":"#cr-split#-10.1016\/j.preghy.2020.06.008_b0020.2","doi-asserted-by":"crossref","unstructured":"(6) (2016) 1072-1079. doi:10.1161\/HYPERTENSIONAHA.116.06421.","DOI":"10.1161\/HYPERTENSIONAHA.116.06421"},{"issue":"5","key":"10.1016\/j.preghy.2020.06.008_b0025","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1586\/17512433.2014.944501","article-title":"Upcoming drugs for the treatment of preeclampsia in pregnant women","volume":"7","author":"Ornaghi","year":"2014","journal-title":"Expert Rev. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.preghy.2020.06.008_b0030","doi-asserted-by":"crossref","first-page":"356.e1","DOI":"10.1016\/j.ajog.2015.12.019","article-title":"Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction","volume":"214","author":"Brownfoot","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"11","key":"10.1016\/j.preghy.2020.06.008_b0035","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1177\/1933719118773484","article-title":"angiogenic dysregulation in pregnancy-related hypertension-a role for metformin","volume":"25","author":"Soobryan","year":"2018","journal-title":"Reprod. Sci."},{"issue":"1","key":"10.1016\/j.preghy.2020.06.008_b0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejogrb.2011.03.024","article-title":"The administration of metformin during pregnancy reduces polycystic ovary syndrome related gestational complications","volume":"157","author":"De Leo","year":"2011","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"5","key":"10.1016\/j.preghy.2020.06.008_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064585","article-title":"Metformin vs insulin in the management of gestational diabetes: a meta-analysis","volume":"8","author":"Gui","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.preghy.2020.06.008_b0050","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/dme.13523","article-title":"Risk of pre-eclampsia in women taking metformin: a systematic review and meta-analysis","volume":"35","author":"Alqudah","year":"2018","journal-title":"Diabet. Med."},{"key":"10.1016\/j.preghy.2020.06.008_b0055","article-title":"Angiogenic capacity in pre-eclampsia and uncomplicated pregnancy estimated by assay of angiogenic proteins and an in vitro vasculogenesis\/angiogenesis test","author":"Virtanen","year":"2018","journal-title":"Angiogenesis"},{"issue":"5","key":"10.1016\/j.preghy.2020.06.008_b0060","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1159\/000336679","article-title":"Adipose stromal cell tubule network model provides a versatile tool for vascular research and tissue engineering","volume":"196","author":"Sarkanen","year":"2012","journal-title":"Cells Tissues Organs"},{"issue":"4","key":"10.1016\/j.preghy.2020.06.008_b0065","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.preghy.2016.08.239","article-title":"Strong inhibitory effect of pre-eclampsia serum on angiogenesis detected in vitro by human cell-based angiogenesis tests","volume":"6","author":"Virtanen","year":"2016","journal-title":"Pregnancy Hypertens."},{"issue":"4","key":"10.1016\/j.preghy.2020.06.008_b0070","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40262-015-0323-x","article-title":"Therapeutic concentrations of metformin: a systematic review","volume":"55","author":"Kajbaf","year":"2016","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.preghy.2020.06.008_b0075","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.reprotox.2016.11.015","article-title":"Intra-laboratory validated human cell-based in vitro vasculogenesis\/angiogenesis test with serum-free medium","volume":"70","author":"Toimela","year":"2017","journal-title":"Reprod Toxicol."},{"issue":"2","key":"10.1016\/j.preghy.2020.06.008_b0080","doi-asserted-by":"crossref","first-page":"125","DOI":"10.14573\/altex.1411271","article-title":"Human vascular model with defined stimulation medium \u2013 a characterization study","volume":"32","author":"Huttala","year":"2015","journal-title":"ALTEX"},{"issue":"5","key":"10.1016\/j.preghy.2020.06.008_b0085","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/bdd.1820","article-title":"Analysis of level A in vitro-in vivo correlations for an extended-release formulation with limited bioavailability","volume":"34","author":"Kakhi","year":"2013","journal-title":"Biopharm. Drug Dispos."},{"issue":"9","key":"10.1016\/j.preghy.2020.06.008_b0090","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1007\/s00125-017-4351-y","article-title":"Metformin use in pregnancy: promises and uncertainties","volume":"60","author":"Lindsay","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.preghy.2020.06.008_b0095","doi-asserted-by":"crossref","DOI":"10.1002\/uog.19084","article-title":"Metformin for prevention of hypertensive disorders of pregnancy in women with gestational diabetes or obesity: systematic review and meta-analysis of randomized trials","author":"Kalafat","year":"2018","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.preghy.2020.06.008_b0100","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ajog.2017.06.003","article-title":"Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity","volume":"217","author":"Romero","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.preghy.2020.06.008_b0105","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/carcin\/bgu001","article-title":"Paradoxic effects of metformin on endothelial cells and angiogenesis","volume":"35","author":"Dallaglio","year":"2014","journal-title":"Carcinogenesis"}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778920300891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778920300891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:54:56Z","timestamp":1761897296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778920300891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":22,"alternative-id":["S2210778920300891"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2020.06.008","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic doses of metformin do not have impact on angiogenesis in presence of sera from pre-eclamptic, IUGR and healthy pregnancies","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2020.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}